Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

R. R. Donnelley & Sons Names Daniel Knotts Chief Operating Officer

R. R. Donnelley & Sons Company (RRD: Quote) announced that Daniel Knotts is being named Chief Operating Officer, succeeding John Paloian. Knotts joined RR Donnelley in 1986 and has served in a variety of accounting, operations, sales leadership and general management roles with progressively more responsibility, including as CEO of RR Donnelley's global Financial Services offering.

Knotts has most recently been the company's Group President, with responsibility for global sales, operations, information technology, logistics, financial services, business process outsourcing operations, strategic sourcing and Environmental, Health and Safety.

Click here to receive FREE breaking news email alerts for R.R. Donnelley & Sons Company and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.